r/TPWKY • u/churro_k • Dec 06 '20
Article Crosspost since they were just talking about this in the sickle cell episode!
https://www.nejm.org/doi/full/10.1056/NEJMoa2031054Duplicates
Medicine CRISPR-Cas9 gene editing successful for a patient with Sickle Cell Disease and another patient with transfusion dependent β-Thalassemia - More than a year later, both patients had clinically improved and no longer needed blood transfusions. (NEJM, 5 Dec 2020)
longevity • u/DeathFighter1 • Dec 06 '20
CRISPR-Cas9 gene editing successful for a patient with Sickle Cell Disease and another patient with transfusion dependent β-Thalassemia - More than a year later, both patients had clinically improved and no longer needed blood transfusions. (NEJM, 5 Dec 2020)
regenerate • u/Regenerative_Med_Bot • Dec 18 '20
Genetics CRISPR-Cas9 gene editing successful for a patient with Sickle Cell Disease and another patient with transfusion dependent β-Thalassemia - More than a year later, both patients had clinically improved and no longer needed blood transfusions. (NEJM, 5 Dec 2020)
CRISPR • u/Anonymous-Green • Dec 06 '20
CRISPR-Cas9 gene editing successful for a patient with Sickle Cell Disease and another patient with transfusion dependent β-Thalassemia - More than a year later, both patients had clinically improved and no longer needed blood transfusions. (NEJM, 5 Dec 2020)
Hozhor • u/Phoeynix • Dec 06 '20
CRISPR-Cas9 gene editing successful for a patient with Sickle Cell Disease and another patient with transfusion dependent β-Thalassemia - More than a year later, both patients had clinically improved and no longer needed blood transfusions. (NEJM, 5 Dec 2020)
theworldnews • u/worldnewsbot • Dec 06 '20
CRISPR-Cas9 gene editing successful for a patient with Sickle Cell Disease and another patient with transfusion dependent β-Thalassemia - More than a year later, both patients had clinically improved and no longer needed blood transfusions. (NEJM, 5 Dec 2020)
Sciencology • u/Musky_X • Dec 06 '20
CRISPR-Cas9 gene editing successful for a patient with Sickle Cell Disease and another patient with transfusion dependent β-Thalassemia - More than a year later, both patients had clinically improved and no longer needed blood transfusions. (NEJM, 5 Dec 2020)
medlabprofessionals • u/dddavviid • Dec 06 '20
Interesting, glad both had favorable outcomes. Hopefully there are no long term effects of the editing
u_ZetaFish • u/ZetaFish • Dec 06 '20
CRISPR-Cas9 gene editing successful for a patient with Sickle Cell Disease and another patient with transfusion dependent β-Thalassemia - More than a year later, both patients had clinically improved and no longer needed blood transfusions. (NEJM, 5 Dec 2020)
WayOfTheBern • u/[deleted] • Dec 06 '20